Abstract
Ocrelizumab (Ocrevus (TM)) is a humanised anti-CD20 monoclonal antibody that has been developed by Genentech, Inc. (a subsidiary of Roche) for the tre......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
